Drug Roundup: New FDA-Approved Treatments in Rheumatology

From a biosimilar to Remicade (infliximab) to new treatments for juvenile arthritis, osteoporosis and fingernail psoriasis, the FDA has approved a number of new treatments for patients with musculoskeletal, rheumatology and other autoimmune-related conditions. In this slideshow, we offer a glance at the new treatments.